Global Infectious Bursal Disease Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
LPI (LP Information)' newest research report, the “Infectious Bursal Disease Vaccine Industry Forecast” looks at past sales and reviews total world Infectious Bursal Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Bursal Disease Vaccine sales for 2023 through 2029. With Infectious Bursal Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Bursal Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Infectious Bursal Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Bursal Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Infectious Bursal Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Bursal Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Bursal Disease Vaccine.
The global Infectious Bursal Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Infectious Bursal Disease Vaccine players cover Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Bursal Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Infectious Bursal Disease Vaccine market?
What factors are driving Infectious Bursal Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Bursal Disease Vaccine market opportunities vary by end market size?
How does Infectious Bursal Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
LPI (LP Information)' newest research report, the “Infectious Bursal Disease Vaccine Industry Forecast” looks at past sales and reviews total world Infectious Bursal Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Bursal Disease Vaccine sales for 2023 through 2029. With Infectious Bursal Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Bursal Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Infectious Bursal Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Bursal Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Infectious Bursal Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Bursal Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Bursal Disease Vaccine.
The global Infectious Bursal Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Infectious Bursal Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Infectious Bursal Disease Vaccine players cover Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Bursal Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Live
- Inactivated
- Veterinary Pharmacy
- Online Sale
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Merck
- Elanco
- Boehringer Ingelheim
- Ceva
- Qingdao Yibang Biological Engineering Co., Ltd.
- Shandong Lvdu Biological Technology Co., Ltd.
- Plyco Bioengineering Co., Ltd.
- Ruipu Biopharmaceutical Co., Ltd.
- Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
What is the 10-year outlook for the global Infectious Bursal Disease Vaccine market?
What factors are driving Infectious Bursal Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Bursal Disease Vaccine market opportunities vary by end market size?
How does Infectious Bursal Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Bursal Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Infectious Bursal Disease Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Infectious Bursal Disease Vaccine Sales by Type
2.3.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Infectious Bursal Disease Vaccine Sale Price by Type (2018-2023)
2.4 Infectious Bursal Disease Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Infectious Bursal Disease Vaccine Sales by Application
2.5.1 Global Infectious Bursal Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Infectious Bursal Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE BY COMPANY
3.1 Global Infectious Bursal Disease Vaccine Breakdown Data by Company
3.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Infectious Bursal Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Bursal Disease Vaccine Product Location Distribution
3.4.2 Players Infectious Bursal Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFECTIOUS BURSAL DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Infectious Bursal Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Infectious Bursal Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Infectious Bursal Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Infectious Bursal Disease Vaccine Sales Growth
4.4 APAC Infectious Bursal Disease Vaccine Sales Growth
4.5 Europe Infectious Bursal Disease Vaccine Sales Growth
4.6 Middle East & Africa Infectious Bursal Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Infectious Bursal Disease Vaccine Sales by Country
5.1.1 Americas Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas Infectious Bursal Disease Vaccine Sales by Type
5.3 Americas Infectious Bursal Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Bursal Disease Vaccine Sales by Region
6.1.1 APAC Infectious Bursal Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC Infectious Bursal Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC Infectious Bursal Disease Vaccine Sales by Type
6.3 APAC Infectious Bursal Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Bursal Disease Vaccine by Country
7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe Infectious Bursal Disease Vaccine Sales by Type
7.3 Europe Infectious Bursal Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Bursal Disease Vaccine by Country
8.1.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type
8.3 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine
10.3 Manufacturing Process Analysis of Infectious Bursal Disease Vaccine
10.4 Industry Chain Structure of Infectious Bursal Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Bursal Disease Vaccine Distributors
11.3 Infectious Bursal Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS BURSAL DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Infectious Bursal Disease Vaccine Market Size Forecast by Region
12.1.1 Global Infectious Bursal Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infectious Bursal Disease Vaccine Forecast by Type
12.7 Global Infectious Bursal Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Elanco
13.3.1 Elanco Company Information
13.3.2 Elanco Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Elanco Main Business Overview
13.3.5 Elanco Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Qingdao Yibang Biological Engineering Co., Ltd.
13.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
13.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Main Business Overview
13.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
13.7 Shandong Lvdu Biological Technology Co., Ltd.
13.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
13.7.2 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shandong Lvdu Biological Technology Co., Ltd. Main Business Overview
13.7.5 Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
13.8 Plyco Bioengineering Co., Ltd.
13.8.1 Plyco Bioengineering Co., Ltd. Company Information
13.8.2 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Plyco Bioengineering Co., Ltd. Main Business Overview
13.8.5 Plyco Bioengineering Co., Ltd. Latest Developments
13.9 Ruipu Biopharmaceutical Co., Ltd.
13.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
13.9.2 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
13.9.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
13.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
13.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
13.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview
13.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Bursal Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Infectious Bursal Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Infectious Bursal Disease Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Infectious Bursal Disease Vaccine Sales by Type
2.3.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Infectious Bursal Disease Vaccine Sale Price by Type (2018-2023)
2.4 Infectious Bursal Disease Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Infectious Bursal Disease Vaccine Sales by Application
2.5.1 Global Infectious Bursal Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Infectious Bursal Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE BY COMPANY
3.1 Global Infectious Bursal Disease Vaccine Breakdown Data by Company
3.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Infectious Bursal Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Bursal Disease Vaccine Product Location Distribution
3.4.2 Players Infectious Bursal Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFECTIOUS BURSAL DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Infectious Bursal Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Infectious Bursal Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Infectious Bursal Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Infectious Bursal Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Infectious Bursal Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Infectious Bursal Disease Vaccine Sales Growth
4.4 APAC Infectious Bursal Disease Vaccine Sales Growth
4.5 Europe Infectious Bursal Disease Vaccine Sales Growth
4.6 Middle East & Africa Infectious Bursal Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Infectious Bursal Disease Vaccine Sales by Country
5.1.1 Americas Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas Infectious Bursal Disease Vaccine Sales by Type
5.3 Americas Infectious Bursal Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Bursal Disease Vaccine Sales by Region
6.1.1 APAC Infectious Bursal Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC Infectious Bursal Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC Infectious Bursal Disease Vaccine Sales by Type
6.3 APAC Infectious Bursal Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Bursal Disease Vaccine by Country
7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe Infectious Bursal Disease Vaccine Sales by Type
7.3 Europe Infectious Bursal Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Bursal Disease Vaccine by Country
8.1.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type
8.3 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine
10.3 Manufacturing Process Analysis of Infectious Bursal Disease Vaccine
10.4 Industry Chain Structure of Infectious Bursal Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Bursal Disease Vaccine Distributors
11.3 Infectious Bursal Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS BURSAL DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Infectious Bursal Disease Vaccine Market Size Forecast by Region
12.1.1 Global Infectious Bursal Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global Infectious Bursal Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Infectious Bursal Disease Vaccine Forecast by Type
12.7 Global Infectious Bursal Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Elanco
13.3.1 Elanco Company Information
13.3.2 Elanco Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Elanco Main Business Overview
13.3.5 Elanco Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Qingdao Yibang Biological Engineering Co., Ltd.
13.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
13.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Main Business Overview
13.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
13.7 Shandong Lvdu Biological Technology Co., Ltd.
13.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
13.7.2 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shandong Lvdu Biological Technology Co., Ltd. Main Business Overview
13.7.5 Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
13.8 Plyco Bioengineering Co., Ltd.
13.8.1 Plyco Bioengineering Co., Ltd. Company Information
13.8.2 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Plyco Bioengineering Co., Ltd. Main Business Overview
13.8.5 Plyco Bioengineering Co., Ltd. Latest Developments
13.9 Ruipu Biopharmaceutical Co., Ltd.
13.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
13.9.2 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
13.9.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
13.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
13.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
13.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
13.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview
13.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Bursal Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Infectious Bursal Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live
Table 4. Major Players of Inactivated
Table 5. Global Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Infectious Bursal Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Infectious Bursal Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Infectious Bursal Disease Vaccine Revenue by Application (2018-2023)
Table 13. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Infectious Bursal Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Infectious Bursal Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Infectious Bursal Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Infectious Bursal Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution and Sales Area
Table 21. Players Infectious Bursal Disease Vaccine Products Offered
Table 22. Infectious Bursal Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Infectious Bursal Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Infectious Bursal Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Infectious Bursal Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Infectious Bursal Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Infectious Bursal Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Infectious Bursal Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Infectious Bursal Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Infectious Bursal Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Infectious Bursal Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Infectious Bursal Disease Vaccine
Table 58. Key Market Challenges & Risks of Infectious Bursal Disease Vaccine
Table 59. Key Industry Trends of Infectious Bursal Disease Vaccine
Table 60. Infectious Bursal Disease Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Infectious Bursal Disease Vaccine Distributors List
Table 63. Infectious Bursal Disease Vaccine Customer List
Table 64. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Infectious Bursal Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Infectious Bursal Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Infectious Bursal Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Infectious Bursal Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Infectious Bursal Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Infectious Bursal Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 80. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Merck Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 85. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Elanco Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Elanco Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 90. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Elanco Main Business
Table 92. Elanco Latest Developments
Table 93. Boehringer Ingelheim Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 95. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boehringer Ingelheim Main Business
Table 97. Boehringer Ingelheim Latest Developments
Table 98. Ceva Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Ceva Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 100. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Ceva Main Business
Table 102. Ceva Latest Developments
Table 103. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 105. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Qingdao Yibang Biological Engineering Co., Ltd. Main Business
Table 107. Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
Table 108. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 110. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Shandong Lvdu Biological Technology Co., Ltd. Main Business
Table 112. Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
Table 113. Plyco Bioengineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 115. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Plyco Bioengineering Co., Ltd. Main Business
Table 117. Plyco Bioengineering Co., Ltd. Latest Developments
Table 118. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 120. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ruipu Biopharmaceutical Co., Ltd. Main Business
Table 122. Ruipu Biopharmaceutical Co., Ltd. Latest Developments
Table 123. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 125. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business
Table 127. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
Table 1. Infectious Bursal Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Infectious Bursal Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live
Table 4. Major Players of Inactivated
Table 5. Global Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Infectious Bursal Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Infectious Bursal Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Infectious Bursal Disease Vaccine Revenue by Application (2018-2023)
Table 13. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Infectious Bursal Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Infectious Bursal Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Infectious Bursal Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Infectious Bursal Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution and Sales Area
Table 21. Players Infectious Bursal Disease Vaccine Products Offered
Table 22. Infectious Bursal Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Infectious Bursal Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Infectious Bursal Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Infectious Bursal Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Infectious Bursal Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Infectious Bursal Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Infectious Bursal Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Infectious Bursal Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Infectious Bursal Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Infectious Bursal Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Infectious Bursal Disease Vaccine
Table 58. Key Market Challenges & Risks of Infectious Bursal Disease Vaccine
Table 59. Key Industry Trends of Infectious Bursal Disease Vaccine
Table 60. Infectious Bursal Disease Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Infectious Bursal Disease Vaccine Distributors List
Table 63. Infectious Bursal Disease Vaccine Customer List
Table 64. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Infectious Bursal Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Infectious Bursal Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Infectious Bursal Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Infectious Bursal Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Infectious Bursal Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Infectious Bursal Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 80. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Merck Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 85. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Elanco Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Elanco Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 90. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Elanco Main Business
Table 92. Elanco Latest Developments
Table 93. Boehringer Ingelheim Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 95. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Boehringer Ingelheim Main Business
Table 97. Boehringer Ingelheim Latest Developments
Table 98. Ceva Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Ceva Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 100. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Ceva Main Business
Table 102. Ceva Latest Developments
Table 103. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 105. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Qingdao Yibang Biological Engineering Co., Ltd. Main Business
Table 107. Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
Table 108. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 110. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Shandong Lvdu Biological Technology Co., Ltd. Main Business
Table 112. Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
Table 113. Plyco Bioengineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 115. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Plyco Bioengineering Co., Ltd. Main Business
Table 117. Plyco Bioengineering Co., Ltd. Latest Developments
Table 118. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 120. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ruipu Biopharmaceutical Co., Ltd. Main Business
Table 122. Ruipu Biopharmaceutical Co., Ltd. Latest Developments
Table 123. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolios and Specifications
Table 125. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business
Table 127. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Infectious Bursal Disease Vaccine
Figure 2. Infectious Bursal Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Bursal Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Infectious Bursal Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Infectious Bursal Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2022
Figure 12. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Infectious Bursal Disease Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Infectious Bursal Disease Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Infectious Bursal Disease Vaccine Consumed in Online Sale
Figure 16. Global Infectious Bursal Disease Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Infectious Bursal Disease Vaccine Consumed in Others
Figure 18. Global Infectious Bursal Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2022)
Figure 20. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application in 2022
Figure 21. Infectious Bursal Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Infectious Bursal Disease Vaccine Sales Market Share by Company in 2022
Figure 23. Infectious Bursal Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Infectious Bursal Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Infectious Bursal Disease Vaccine
Figure 74. Industry Chain Structure of Infectious Bursal Disease Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Infectious Bursal Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Infectious Bursal Disease Vaccine
Figure 2. Infectious Bursal Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Bursal Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Infectious Bursal Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Infectious Bursal Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2022
Figure 12. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Infectious Bursal Disease Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Infectious Bursal Disease Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Infectious Bursal Disease Vaccine Consumed in Online Sale
Figure 16. Global Infectious Bursal Disease Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Infectious Bursal Disease Vaccine Consumed in Others
Figure 18. Global Infectious Bursal Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2022)
Figure 20. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application in 2022
Figure 21. Infectious Bursal Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Infectious Bursal Disease Vaccine Sales Market Share by Company in 2022
Figure 23. Infectious Bursal Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Infectious Bursal Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Infectious Bursal Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Infectious Bursal Disease Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Infectious Bursal Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Infectious Bursal Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Infectious Bursal Disease Vaccine
Figure 74. Industry Chain Structure of Infectious Bursal Disease Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Infectious Bursal Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
